Andrew Chang, PhD Novo Nordisk

Chang is a multifaceted quality and CMC leader with 28 years of experience in medical product regulation. Chang is the chair for the BioAB at the PDA and a Board of Director for PDA and CASSS-Sharing Science Solutions. In Chang's current role as a Vice President of Quality and Regulatory Compliance, Regulatory Policy and Intelligence and Global Regulatory Affairs at Novo Nordisk, he provides strategic leadership on regulatory and quality related policy, external Affairs, strategic advice and solutions to quality and regulatory-related challenges.